BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1860212)

  • 1. Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
    Braden GA; Knapp HR; FitzGerald GA
    Circulation; 1991 Aug; 84(2):679-85. PubMed ID: 1860212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile.
    Force T; Milani R; Hibberd P; Lorenz R; Uedelhoven W; Leaf A; Weber P
    Circulation; 1991 Dec; 84(6):2286-93. PubMed ID: 1959184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy.
    Brezinski DA; Nesto RW; Serhan CN
    Circulation; 1992 Jul; 86(1):56-63. PubMed ID: 1617790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibition of thromboxane A2 and prostacyclin synthesis by low dose acetylsalicylic acid in atherosclerotic patients.
    Carlsson I; Benthin G; Petersson AS; Wennmalm A
    Thromb Res; 1990 Feb; 57(3):437-44. PubMed ID: 2107595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
    Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo.
    Braden GA; Knapp HR; Fitzgerald DJ; FitzGerald GA
    Circulation; 1990 Jul; 82(1):178-87. PubMed ID: 2114234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn.
    Viinikka L; Hartikainen-Sorri AL; Lumme R; Hiilesmaa V; Ylikorkala O
    Br J Obstet Gynaecol; 1993 Sep; 100(9):809-15. PubMed ID: 8217999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty.
    Ciabattoni G; Ujang S; Sritara P; Andreotti F; Davies G; Simonetti BM; Patrono C; Maseri A
    J Am Coll Cardiol; 1993 May; 21(6):1377-81. PubMed ID: 8473644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
    Knapp HR; Reilly IA; Alessandrini P; FitzGerald GA
    N Engl J Med; 1986 Apr; 314(15):937-42. PubMed ID: 3007982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-dose aspirin in combination with stable fish oil on whole blood production of eicosanoids.
    Engström K; Wallin R; Saldeen T
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):291-7. PubMed ID: 11427037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.
    Weksler BB; Tack-Goldman K; Subramanian VA; Gay WA
    Circulation; 1985 Feb; 71(2):332-40. PubMed ID: 3880671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation.
    Krämer HJ; Stevens J; Grimminger F; Seeger W
    Biochem Pharmacol; 1996 Oct; 52(8):1211-7. PubMed ID: 8937428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease.
    Patrignani P
    Thromb Res; 2003 Jun; 110(5-6):281-6. PubMed ID: 14592549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of dietary fish oil on myocardial prostaglandin I2 and thromboxane A2 production.
    Abeywardena MY; McLennan PL; Charnock JS
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H379-85. PubMed ID: 1899979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of thromboxane A2, prostacyclin and other eicosanoids in the cardiovascular system.
    Müller B
    Therapie; 1991; 46(3):217-21. PubMed ID: 1792655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of various doses of acetylsalicylic acid in combination with dipyridamole on the balance between prostacyclin and thromboxane in human serum.
    Viinikka L; Ylikorkala O
    Br J Pharmacol; 1981 Feb; 72(2):299-303. PubMed ID: 7011467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.